Search Results - "GUINDO, Merepen A"

A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali by Diakité, Seidina A S, Traoré, Karim, Sanogo, Ibrahim, Clark, Taane G, Campino, Susana, Sangaré, Modibo, Dabitao, Djeneba, Dara, Antoine, Konaté, Drissa S, Doucouré, Fousseyni, Cissé, Amadou, Keita, Bourama, Doumbouya, Mory, Guindo, Merepen A, Toure, Mahamoudou B, Sogoba, Nafomon, Doumbia, Seydou, Awandare, Gordon A, Diakité, Mahamadou

“…Drug resistance is one of the greatest challenges of malaria control programme in Mali. Recent advances in next-generation sequencing (NGS) technologies…”
Get full text

Ultra-sensitive RDT performance and antigen dynamics in a high-transmission Plasmodium falciparum setting in Mali by Reichert, Emily N, Hume, Jen C C, Sagara, Issaka, Healy, Sara A, Assadou, Mahamadoun H, Guindo, Merepen A, Barney, Rebecca, Rashid, Andy, Yang, Ihn Kyung, Golden, Allison, Domingo, Gonzalo J, Duffy, Patrick E, Slater, Hannah C

“…The recent expansion of tools designed to accurately quantify malaria parasite-produced antigens has enabled us to evaluate the performance of rapid diagnostic…”
Get full text

Seroprevalence of SARS‐CoV‐2 Antibodies and Associated Factors in Bamako, Mali: A Population‐Based Cross‐Sectional Study in September 2022 by Traoré, Bourama, Guindo, Merepen A., Konaté, Drissa, Kané, Fousseyni, Incandela, Nathan C., Traore, Abdouramane, Kanté, Salimata, Sidibé, Mariam, Keita, Bourama, Kasse, Fatoumata, Tangara, Karamoko, Diallo, Dramane, Maiga, Issoufi Y., Thiam, Salif, Cisse, Abdourhamane, Siby, Khatry M., Dicko, Abdoul R., Goita, Mariam, Kone, Diakaridia, Diallo, Mamadou, Traore, Modibo, Coulibaly, Yaya I., Diakité, Mahamadou, Doumbia, Seydou, Dolo, Housseini, Balam, Saidou

“…ABSTRACT Background The sero‐epidemiological characteristics of SARS‐CoV‐2 infections in Mali are not yet well understood. This study assessed SARS‐CoV‐2…”
Get full text

Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas by Traoré, Abdouramane, Guindo, Merepen A, Konaté, Drissa, Traoré, Bourama, Diakité, Seidina A, Kanté, Salimata, Dembélé, Assitan, Cissé, Abdourhamane, Incandela, Nathan C, Kodio, Mamoudou, Coulibaly, Yaya I, Faye, Ousmane, Kajava, Andrey V, Pratesi, Federico, Migliorini, Paola, Papini, Anna Maria, Pacini, Lorenzo, Rovero, Paolo, Errante, Fosca, Diakité, Mahamadou, Arevalo-Herrera, Myriam, Herrera, Socrates, Corradin, Giampietro, Balam, Saidou

“…Despite the global interest and the unprecedented number of scientific studies triggered by the COVID-19 pandemic, few data are available from developing and…”
Get full text

A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali by Sagara, Issaka, Dicko, Alassane, Ellis, Ruth D, Fay, Michael P, Diawara, Sory I, Assadou, Mahamadoun H, Sissoko, Mahamadou S, Kone, Mamady, Diallo, Abdoulbaki I, Saye, Renion, Guindo, Merepen A, Kante, Ousmane, Niambele, Mohamed B, Miura, Kazutoyo, Mullen, Gregory E.D, Pierce, Mark, Martin, Laura B, Dolo, Amagana, Diallo, Dapa A, Doumbo, Ogobara K, Miller, Louis H, Saul, Allan

“…Abstract A double blind, randomized, controlled Phase 2 clinical trial was conducted to assess the safety, immunogenicity, and biologic impact of the vaccine…”
Get full text

Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali by Traoré, Karim, Diakité, Seidina A. S., Bah, Sekou, Konaté, Drissa S., Dabitao, Djeneba, Sanogo, Ibrahim, Sangaré, Modibo, Dama, Souleymane, Keita, Bourama, Doumbouya, Mory, Guindo, Merepen A., Doumbia, Seydou, Diakité, Mahamadou

“…Background In 2006, the National Malaria Control Program in Mali recommended artemisinin-based combination therapy as the first-line treatment for…”
Get full text

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults by Sagara, Issaka, Ellis, Ruth D, Dicko, Alassane, Niambele, Mohamed B, Kamate, Beh, Guindo, Ousmane, Sissoko, Mahamadou S, Fay, Michael P, Guindo, Merepen A, Kante, Ousmane, Saye, Renion, Miura, Kazutoyo, Long, Carole, Mullen, Gregory E.D, Pierce, Mark, Martin, Laura B, Rausch, Kelly, Dolo, Amagana, Diallo, Dapa A, Miller, Louis H, Doumbo, Ogobara K

“…Abstract A double blind, randomized and controlled Phase 1 clinical trial was conducted to assess the safety and immunogenicity in malaria-exposed adults of…”
Get full text

Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial by Sissoko, Mahamadou S, Healy, Sara A, Katile, Abdoulaye, Zaidi, Irfan, Hu, Zonghui, Kamate, Bourama, Samake, Yacouba, Sissoko, Kourane, Mwakingwe-Omari, Agnes, Lane, Jacquelyn, Imeru, Alemush, Mohan, Rathy, Thera, Ismaila, Guindo, Cheick Oumar, Dolo, Amagana, Niare, Karamoko, Koïta, Fanta, Niangaly, Amadou, Rausch, Kelly M, Zeguime, Amatigue, Guindo, Merepen A, Bah, Aissatou, Abebe, Yonas, James, Eric R, Manoj, Anita, Murshedkar, Tooba, KC, Natasha, Sim, B Kim Lee, Billingsley, Peter F, Richie, Thomas L, Hoffman, Stephen L, Doumbo, Ogobara, Duffy, Patrick E

“…WHO recently approved a partially effective vaccine that reduces clinical malaria in children, but increased vaccine activity is required to pursue malaria…”
Get full text

Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial by Sagara, Issaka, Healy, Sara A, Assadou, Mahamadoun H, Kone, Mamady, Swihart, Bruce J, Kwan, Jennifer L, Fintzi, Jonathan, Sissoko, Kourane, Kamate, Bourama, Samake, Yacouba, Guindo, Merepen A, Doucoure, M'Bouye, Niaré, Karamoko, Dolo, Amagana, Diarra, Balla, Rausch, Kelly M, Narum, David L, Jones, David S, MacDonald, Nicholas J, Zhu, Daming, Gorres, J Patrick, Imeru, Alemush, Mohan, Rathy, Thera, Ismaila, Zaidi, Irfan, Salazar-Miralles, Fernando, Duan, Junhui, Neal, Jillian, Morrison, Robert D, Muratova, Olga, Sylla, Daman, O'Connell, Elise M, Wu, Yimin, Hume, Jen C C, Coulibaly, Mamadou B, Anderson, Charles F, Traore, Sekou F, Doumbo, Ogobara K, Duffy, Patrick E

“…Malaria transmission-blocking vaccines target mosquito-stage parasites and will support elimination programmes. Gamete vaccine Pfs230D1-EPA/Alhydrogel induced…”
Get full text

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults by Sagara, Issaka, Healy, Sara A, Assadou, Mahamadoun H, Gabriel, Erin E, Kone, Mamady, Sissoko, Kourane, Tembine, Intimbeye, Guindo, Merepen A, Doucoure, M'Bouye, Niaré, Karamoko, Dolo, Amagana, Rausch, Kelly M, Narum, David L, Jones, David L, MacDonald, Nicholas J, Zhu, Daming, Mohan, Rathy, Muratova, Olga, Baber, Ibrahima, Coulibaly, Mamadou B, Fay, Michael P, Anderson, Charles, Wu, Yimin, Traore, Sekou F, Doumbo, Ogobara K, Duffy, Patrick E

“…Pfs25H-EPA is a protein-protein conjugate transmission-blocking vaccine against Plasmodium falciparum that is safe and induces functional antibodies in…”
Get full text

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine by Ellis, Ruth D, Fay, Michael P, Sagara, Issaka, Dicko, Alassane, Miura, Kazutoyo, Guindo, Merepen A, Guindo, Aldiouma, Sissoko, Mahamadou S, Doumbo, Ogobara K, Diallo, Dapa

“…A Phase 1-2b study of the blood stage malaria vaccine AMA1-C1/Alhydrogel was conducted in 336 children in Donéguébougou and Bancoumana, Mali. In the Phase 2…”
Get full text

Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali by Doucoure, M'Bouye, Zeguime, Amatigue, Niangaly, Amadou, Guindo, Merepen A, Doritchamou, Justin Y A, Assadou, Mahamadoun H, Katile, Abdoulaye, Kanoute, Moussa B, Perou, Sidiki, Ouattara, Adama, Sanogo, Sintry, Ouologuem, Boucary, Traore, Souleymane, Dao, Bakary, Dembele, Drissa, Kone, Mamady, Kamate, Bourama, Sissoko, Kourane, Sankare, Seydou, Diarra, Sadio, Dolo, Amagana, Sissoko, Mahamadou S, Hume, Jennifer C C, Cook, David, Healy, Sara A, Gorres, J Patrick, Traoré, Boubacar, Gamiel, Jordyn, Duffy, Patrick E, Sagara, Issaka

“…The interpretation of a laboratory test result requires an appropriate reference range established in healthy subjects, and normal ranges may vary by factors…”
Get more information

Promoting Good Clinical Laboratory Practices and Laboratory Accreditation to Support Clinical Trials in Sub-Saharan Africa by GUINDO, Merepen A, SHOTT, Joseph P, DIALLO, Dapa A, DOUMBO, Ogobara K, SAYE, Renion, DIAKITE, Moussa L, SANOGO, Sintry, DEMBELE, Moussa B, KEITA, Sekouba, NAGEL, Mary C, ELLIS, Ruth D, AEBIG, Joan A

“…Laboratory capacity in the developing world frequently lacks quality management systems (QMS) such as good clinical laboratory practices, proper safety…”
Get full text

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial by Sissoko, Mahamadou S, MD, Healy, Sara A, MD, Katile, Abdoulaye, MD, Omaswa, Freda, MD, Zaidi, Irfan, PhD, Gabriel, Erin E, PhD, Kamate, Bourama, MD, Samake, Yacouba, MD, Guindo, Merepen A, PharmD, Dolo, Amagana, PharmD, Niangaly, Amadou, PharmD, Niaré, Karamoko, PharmD, Zeguime, Amatigue, PharmD, Sissoko, Kourane, MD, Diallo, Hama, MD, Thera, Ismaila, MSc, Ding, Kelly, PhD, Fay, Michael P, PhD, O'Connell, Elise M, MD, Nutman, Thomas B, MD, Wong-Madden, Sharon, BA, Murshedkar, Tooba, MS, Ruben, Adam J, PhD, Li, Minglin, PhD, Abebe, Yonas, MS, Manoj, Anita, PhD, Gunasekera, Anusha, PhD, Chakravarty, Sumana, PhD, Sim, B Kim Lee, PhD, Billingsley, Peter F, PhD, James, Eric R, PhD, Walther, Michael, PhD, Richie, Thomas L, MD, Hoffman, Stephen L, MD, Doumbo, Ogobara, Prof, Duffy, Patrick E, Dr

“…Summary Background Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria sporozoite vaccine that has been…”
Get full text

A randomized controlled phase 1 trial of malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel® in healthy Malian adults by Sagara, Issaka, Healy, Sara A., Assadou, Mahamadoun H., Kone, Mamady, Swihart, Bruce J., Kwan, Jennifer L., Fintzi, Jonathan, Sissoko, Kourane, Kamate, Bourama, Samake, Yacouba, Guindo, Merepen A., Doucoure, M’Bouye, Niaré, Karamoko, Dolo, Amagana, Diarra, Balla, Rausch, Kelly M., Narum, David L., Jones, David S., MacDonald, Nicholas J., Zhu, Daming, Gorres, J. Patrick, Imeru, Alemush, Mohan, Rathy, Thera, Ismaila, Zaidi, Irfan, Salazar-Miralles, Fernando, Duan, Junhui, Neal, Jillian, Morrison, Robert D., Muratova, Olga, Sylla, Daman, O’Connell, Elise M., Wu, Yimin, Hume, Jen. C.C., Coulibaly, Mamadou B., Anderson, Charles F., Traore, Sekou F., Doumbo, Ogobara K., Duffy, Patrick E.

Get full text

Three dose regimen of PfSPZ Vaccine protects adult Malians against Plasmodium falciparum through an intense transmission season: a randomised, controlled phase I trial by Sissoko, Mahamadou S., Healy, Sara A., Katile, Abdoulaye, Zaidi, Irfan, Hu, Zonghui, Kamate, Bourama, Samake, Yacouba, Sissoko, Kourane, Mwakingwe-Omari, Agnes, Lane, Jacquelyn, Imeru, Alemush, Mohan, Rathy, Thera, Ismaila, Oumar Guindo, Cheick, Dolo, Amagana, Niare, Karamoko, Koïta, Fanta, Niangaly, Amadou, Rausch, Kelly M., Zeguime, Amatigue, Guindo, Merepen A., Bah, Aissatou, Abebe, Yonas, James, Eric R., Manoj, Anita, Murshedkar, Tooba, KC, Natasha, Sim, B. Kim Lee, Billingsley, Peter F., Richie, Thomas L., Hoffman, Stephen L., Doumbo, Ogobara, Duffy, Patrick E.

Get full text

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel®, a transmission blocking vaccine against Plasmodium falciparum: a randomized, double-blind, comparator-controlled, dose-escalation study in healthy malaria exposed Malian adults by Sagara, Issaka, Healy, Sara A., Assadou, Mahamadoun H, Gabriel, Erin E., Kone, Mamady, Sissoko, Kourane, Tembine, Intimbeye, Guindo, Merepen A., Doucoure, M’Bouye, Niaré, Karamoko, Dolo, Amagana, Rausch, Kelly M., Narum, David L., Jones, David L., MacDonald, Nicholas J, Zhu, Daming, Mohan, Rathy, Muratova, Olga, Baber, Ibrahima, Coulibaly, Mamadou B., Fay, Michael P., Anderson, Charles, Wu, Yimin, Traore, Sekou F, Doumbo, Ogobara K., Duffy, Patrick E.

Get full text

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine forPlasmodium falciparummalaria in semi-immune Malian adults by Sagara, Issaka, Ellis, Ruth D, Dicko, Alassane, Niambele, Mohamed B, Kamate, Beh, Guindo, Ousmane, Sissoko, Mahamadou S, Fay, Michael P, Guindo, Merepen A, Kante, Ousmane, Saye, Renion, Miura, Kazutoyo, Long, Carole, Mullen, Gregory ED, Pierce, Mark, Martin, Laura B, Rausch, Kelly, Dolo, Amagana, Diallo, Dapa A, Miller, Louis H, Doumbo, Ogobara K

“…A double blind, randomized and controlled Phase 1 clinical trial was conducted to assess the safety and immunogenicity in malaria-exposed adults of…”
Get full text